CCAP logo

Crescent Capital BDC, Inc. Stock Price

NasdaqGM:CCAP Community·US$407.1m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

CCAP Share Price Performance

US$11.05
-3.36 (-23.32%)
US$14.00
Fair Value
US$11.05
-3.36 (-23.32%)
21.1% undervalued intrinsic discount
US$14.00
Fair Value
Price US$11.05
AnalystConsensusTarget US$14.00
AnalystHighTarget US$16.00
AnalystLowTarget US$13.00

CCAP Community Narratives

·
Fair Value US$14 21.1% undervalued intrinsic discount

Private Credit Demand And Stable Funding Structure Will Support Long-Term Earnings Resilience

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$16 30.9% undervalued intrinsic discount

Private Credit Tailwinds And First Lien Focus Will Support A Stronger Future

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$13 15.0% undervalued intrinsic discount

Private Credit Adoption And Covenant Strength Will Shape Future Earnings Stability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$16
30.9% undervalued intrinsic discount
Revenue
-6.12% p.a.
Profit Margin
48.83%
Future PE
12.43x
Price in 2029
US$22.63
US$13
15.0% undervalued intrinsic discount
Revenue
-5.5% p.a.
Profit Margin
43.16%
Future PE
10.92x
Price in 2029
US$18.22

Trending Discussion

No trending discussion available.

Updated Narratives

CCAP logo

CCAP: Higher Margins And Special Dividends Will Support Future Upside

Fair Value: US$16 30.9% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCAP logo

CCAP: Higher Margins And Special Dividends Will Support Bullish Outlook

Fair Value: US$14 21.1% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCAP logo

Private Credit Adoption And Covenant Strength Will Shape Future Earnings Stability

Fair Value: US$13 15.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Slight risk with moderate growth potential.

4 Risks
3 Rewards

Crescent Capital BDC, Inc. Key Details

US$163.1m

Revenue

US$0

Cost of Revenue

US$163.1m

Gross Profit

US$148.0m

Other Expenses

US$15.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.41
100.00%
9.25%
134.8%
View Full Analysis

About CCAP

Founded
2015
Employees
n/a
CEO
Jason Breaux
WebsiteView website
www.crescentbdc.com

Crescent Capital BDC, Inc. is as a business development company is a private debt fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Recent CCAP News & Updates

Narrative Update Jul 10

CCAP: Higher Margins And Special Dividends Will Support Future Upside

The Analyst Price Target for Crescent Capital BDC has been revised from $19 to $16, with analysts citing updated assumptions around discount rates, revenue trends, profit margins, and future P/E as the basis for the change. What’s in the News for Crescent Capital BDC Crescent Capital BDC declared a second quarter 2026 regular cash dividend of $0.34 per share, payable on July 15, 2026, to stockholders of record as of June 30, 2026.
Seeking Alpha Jul 06

Crescent Capital: Why I Still Wouldn't Buy Even After The 19% Dividend Cut

Summary Crescent Capital BDC, Inc. faces ongoing headwinds, with a 19% dividend cut following rising non-accruals and declining investment income. Despite a steep 39% discount to NAV and a 12%+ yield, I remain cautious given persistent inflation and potential for further downside. CCAP's Q1 saw net investment income drop to $0.38/share and non-accruals spike to 5.7% at cost, pressuring NAV and dividend sustainability. While balance sheet flexibility exists, risks of further non-accruals and dividend cuts outweigh the appeal of current CCAP stock valuation and yield. Read the full article on Seeking Alpha
Narrative Update Jun 26

CCAP: Higher Margins And Special Dividends Will Support Bullish Outlook

Analysts have reduced their 12‑month price target for Crescent Capital BDC from $15.75 to $14.00, citing updated assumptions about discount rates, revenue trends, profit margins, and a lower projected future P/E multiple. What’s in the News for Crescent Capital BDC Crescent Capital BDC announced that its Board of Directors declared a second quarter 2026 regular cash dividend of $0.34 per share, with a record date of June 30, 2026 and a payment date of July 15, 2026.

Recent updates

No updates